NEW YORK (GenomeWeb) – Opko Health's GeneDx business today announced it has extended an existing relationship with the University of California.
A spokeswoman with GeneDx said that one medical center in the UC Health network previously had been working with the firm, and the extension means that all five of the university system's medical centers plus its affiliates, will now work with GeneDx.
"The contract formalizes the relationship and essentially gives them license to send more [work] and track physician utilization to ensure that the right test is ordered at the right time," she said in an email. UC Health will have access to more than 400 tests for rare hereditary disorders, she added.
Financial and other terms of the deal were not disclosed.
In a statement Gregory Henderson, president of BioReference Laboratories, of which GeneDx is a business unit, said "[w]hole-exome sequencing and other clinical services offered by GeneDx will give UC Health's world-class doctors, genetic counselors, and other clinicians actionable insight into some of the most pressing health challenges faced by their patients."